Shenzhen Core Medical Technology Co.,ltd.

This study tests a new device called the Corheart 6, a heart pump for people with end-stage heart failure who are not helped by standard medicines. About 50 adults will receive the pump to see if it helps them live longer and avoid serious strokes. The goal is to keep patients al…

This study compares a new heart pump (CorVad) to standard ECMO support in 262 high-risk patients undergoing complex angioplasty. These patients have severe coronary artery disease and weak hearts, making the procedure risky. The goal is to see if the new pump reduces major compli…